Back
Lithium Americas Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
44
LAC
Lithium Americas
Last Price:
2.86
Seasonality Move:
24.55%
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
Sell
44
Lithium Americas (LAC)
is a Sell
Is Lithium Americas a Buy, Sell or Hold?
- The current Lithium Americas [LAC] share price is $2.84. The Score for LAC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- LAC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LAC Stock Price Chart
What is Lithium Americas's stock price today?
-
The Lithium Americas share price today is $2.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LAC is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $38.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
LAC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 23.17 | Sell |
Chaikin Money Flow: | 2244929 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.89 - 4.03) | Sell |
Bollinger Bands (100): | (3.59 - 6.07) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.74 | Sell |
Relative Strength Index (14 RSI): | 40.05 | Sell |
Chaikin Money Flow: | 76134 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.06 - 42.34) | Sell |
Bollinger Bands (100): | (41.13 - 48.85) | Sell |
LAC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.9 | Sell |
20-day SMA: | 3.22 | Sell |
50-day SMA: | 4.27 | Sell |
200-day SMA: | 5.94 | Sell |
8-day EMA: | 2.92 | Sell |
20-day EMA: | 3.26 | Sell |
50-day EMA: | 4.03 | Sell |
200-day EMA: | 5.66 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.68 | Sell |
20-day SMA: | 40.48 | Sell |
50-day SMA: | 42.18 | Sell |
200-day SMA: | 42.45 | Sell |
8-day EMA: | 39.81 | Sell |
20-day EMA: | 40.64 | Sell |
50-day EMA: | 42.13 | Sell |
200-day EMA: | 43.5 | Sell |
Lithium Americas Earnings Growth & LAC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.08 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Lithium Americas Technical Analysis
Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |